Exercise plus cognitive behavioural therapy for fatigue in women treated for breast cancer in Singapore
Official title: Pilot Study of Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in Singapore
Run by National Cancer Centre, Singapore · NCT07116161 · Data updated 2026-11-12
This program tests whether graded exercise combined with cognitive behavioural therapy can reduce fatigue and help women with breast cancer stay on their treatment plans.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | National Cancer Centre, Singapore Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 4 sites (Singapore and 3 other locations) |
| Status | Recruiting |
| Started | July 14, 2025 |
| Main results expected | April 30, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | May 29, 2026 |
| Trial ID | NCT07116161 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking women aged 21 or older with stage I–III breast cancer who have completed surgery (and adjuvant chemotherapy if indicated) and report significant fatigue (one-item fatigue score ≥4).
✕Probably not a fit
Patients who are pregnant or lactating, medically unable to undertake graded exercise, do not report significant fatigue, or cannot attend in-person visits or communicate in English are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, controlled pilot intervention enrolling 100 women across National Cancer Centre Singapore, Singapore General Hospital and NCCS satellite clinics to test graded exercise therapy with or without added cognitive behavioural therapy. Ninety participants form the primary cohort (stage I–III who have completed surgery and adjuvant chemotherapy if indicated) and ten form an exploratory cohort (stage IV on systemic therapy). Participants are screened using routine referrals, the distress thermometer, and a one-item fatigue scale (score ≥4) and provide informed consent before randomization. Primary outcomes include acceptability, feasibility, fatigue levels, and treatment adherence over the study period.
Why it matters
Potential benefit: If successful, combining graded exercise and CBT could meaningfully reduce cancer-related fatigue and improve adherence to breast cancer treatments and daily functioning.
How similar studies have gone: Prior trials have shown that exercise programs and cognitive behavioural therapy can each reduce cancer-related fatigue, though combining them in this specific Singapore clinical setting is being tested here.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Primary cohort (N=90): 1. Female 2. ≥21 years of age 3. Stage I-III breast cancer regardless of hormone receptor status or human epidermal growth factor receptor 2 (HER2) status 4. Completed surgery 5. Completed adjuvant chemotherapy, if indicated 6. Reported fatigue (One-item fatigue scale score ≥ 4) 7. Ability to read and communicate in English 8. Willing to provide informed consent for the study participation Exploratory cohort (N=10): 1. Female 2. ≥21 years of age 3. Stage IV breast cancer regardless of hormone receptor status or human epidermal growth factor receptor 2 (HER2) status 4. Completed surgery 5. Currently receiving systemic therapy (e.g. endocrine therapy, chemotherapy, targeted therapy or immunotherapy) 6. Reported fatigue (One-item fatigue scale score ≥ 4) 7. Ability to read and communicate in English 8. Willing to provide informed consent for the study participation Exclusion Criteria for both cohorts: 1. Pregnant or lactating 2. Presence of dementia or major psychiatric disease 3. Deemed medically unsuitable by medical team for low to moderate intensity exercise 4. Unable or unwilling for tele-counselling sessions 5. Uncontrolled pain or undiagnosed pain 6. Low blood counts: Hb \<8.0, Platelet \<50K, ANC \<1 7. Electrolyte imbalances: K \<3.0, Na \<130 8. Cardiovascular diseases, including but not limited to: LVEF \<35%, uncontrolled arrhythmias, severe coronary artery disease, severe valvular heart disease, uncontrolled hypertension etc. not cleared by a cardiologist 9. Active infection 10. Currently engaged in moderate to vigorous physical activity
Where it's running
-
National Cancer Centre, Singapore (NCCS)
Singapore, Singapore Recruiting -
Singapore General Hospital
Singapore, Singapore Recruiting -
NCCS Satellite Clinic @ Changi General Hospital
Singapore, Singapore Recruiting -
NCCS Satellite Clinic @ Sengkang General Hospital
Singapore, Singapore Recruiting
Study contacts
- Principal investigator: Dr Ryan Shea YC TAN, MBBS, MRCP(UK), MMed — National Cancer Centre, Singapore
- Study coordinator: Dr Ryan Shea YC TAN, MBBS, MRCP(UK), MMed
- Email: ryan.shea.tan.y.c@singhealth.com.sg
- Phone: +65 63065771
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oncoliq blood test for early detection of breast cancer
This project will test whether a blood-based miRNA panel (the Oncoliq Test) can detect early breast cancer in adults 40–70 by comparing newly diagnosed, untreated patients with cancer-free controls.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Micro-choice-based approach to fatigue management
A small study in Basel will test a new four-day group program using micro-choices to help people with fatigue from multiple causes see if it’s doable, acceptable, and may help daily functioning.
-
HBS-301 for Narcolepsy: daily wakefulness and sleepiness improvement in adults
This Phase 3 study tests HBS-301 vs placebo in adults with narcolepsy to see if it helps with daytime sleepiness, cataplexy, sleepiness, and fatigue.
-
See if Nuvastatic helps with cancer-related fatigue in colon cancer patients on first-line chemotherapy
This trial tests whether Nuvastatic can lessen fatigue in adults with colon cancer who are receiving their first round of chemotherapy, compared to placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.